Friday, 30 Oct 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14778
Articles
Company
Drug
Belief BioMed’s Hemophilia B Gene Therapy BBM-H901 Slated for Priority Review in China
October 14, 2024
Policy / Regulatory
NHSA Report: China’s Medical Insurance Fund Records Significant Growth and Savings in 2023
October 14, 2024
Company
Deals
CanSino Biologics Partners with Malaysia’s NIBM to Develop mRNA Influenza Vaccine
December 23, 2024
Company
Deals
Shanghai’s Spectrum Dynamics Medical Secures Major Financing for Molecular Imaging Innovations
October 14, 2024
Company
Deals
Shanghai GenTech Expands into Life Sciences with Acquisition of Konosai Biotechnology
October 14, 2024
Company
Deals
Innovent Biologics Partners with Wecomput Technology to Accelerate AI in Drug Development
October 14, 2024
Company
Deals
United Imaging Healthcare Invests RMB 120 Million in Particle Accelerator Specialist Long Beam Technology
October 14, 2024
Company
Drug
Sinqi Pharmaceutical Gets NMPA Green Light for SQ-22031 Eye Drops to Treat Dry Eye Syndrome and Neurotrophic Keratitis
October 14, 2024
Company
Medical Device
Lepu Scientech Secures NMPA Approval for RF Lance, Advancing Atrial Septal Puncture Technology
October 14, 2024
Company
Medical Device
Amoy Diagnostics’ APACE Receives Japanese Approval as Companion Diagnostic for MET-Inhibiting Therapies
October 14, 2024
Company
Drug
China’s NMPA Gives Tacit Nod to IASO Biotechnology’s IASO-782 for SLE Clinical Trials
December 4, 2024
Company
Drug
Luye Pharma’s Subsidiary Gets NMPA Go-Ahead for First CD228-Targeted ADC BA1302
October 14, 2024
1
2
…
661
662
663
664
665
…
1,231
1,232
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?